What we found on the web about Paclitaxel
Paclitaxel is a mitotic inhibitor used in cancer chemotherapy. It was discovered in a National Cancer Institute program at the Research Triangle Institute in 1967 when Monroe E ...
Paclitaxel total synthesis in organic chemistry is a major ongoing research effort in the total synthesis of paclitaxel (Taxol). This diterpenoid is an important drug in the ...
Paclitaxel is an anti-cancer chemotherapy drug classified as a plant alkaloid, a ... The nurse or doctor who gives Paclitaxel must be carefully trained. ...
Drug details for Paclitaxel. ... Paclitaxel is an intravenous (IV) medication. ... Paclitaxel slows or stops the growth and spread of cancer cells in the body. ...
Consumer information about the medication PACLITAXEL - INJECTION (Taxol), includes side effects, drug interactions, recommended dosages, and storage information. Read more about ...
In addition, paclitaxel induces abnormal arrays of microtubule bundles ... Peak plasma concentrations of paclitaxel following IV administration exhibit ...
pac·li·tax·el (p k l-t k s l) n. An anticancer drug derived from the bark of the Pacific yew tree and used in the treatment of ovarian and breast cancer that has not responded ...
Before you receive paclitaxel, tell your doctor if you have liver disease, heart disease, or a severely ... information I should know about paclitaxel? ...
P aclitaxel and docetaxel are taxoid drugs extracted from the bark of the Pacific yew and the needles of the English yew, respectively. Both work against cancer by interfering with ...
paclitaxel /pac·li·tax·el/ (pak″lĭ-tak´sel) an antineoplastic that promotes and stabilizes polymerization of microtubules, isolated from the Pacific yew tree (Taxus ...
The goal of this study was to determine the formulation dependence of paclitaxel ... Paclitaxel was administered intravenously in either multilamellar (MLV) ...
(paclitaxel) should be administered under the supervision of a physician ... Paclitaxel is a novel antimicrotubule agent that promotes the assembly of microtubules ...
paclitaxel buyers directory - over 3,000,000 registered importers and exporters. paclitaxel importers, paclitaxel buyers, paclitaxel purchasers, resellers, traders and paclitaxel ...
Here is what users have to say about Paclitaxel

{{drugbox | | IUPAC_name = (2α,​4α,​5β,​7β,​10β,​13α)-​4,​10-​bis(acetyloxy)-​13-​{1​oxy}-​1,​7-​dihydroxy-​9-​oxo-​5,​20-​epoxytax-​11-​en-​2-​yl benzoate | image = Taxol.svg | width = 350 | image2 = Taxol(Paclitaxel)3D.png | CAS_number = 33069-62-4 | ChemSpiderID = 10368587 | ATC_prefix = L01 | ATC_suffix = CD01 | ATC_supplemental =
ATC: CD03 (paclitaxel poliglumex) | PubChem = 36314 | DrugBank = APRD00259 | C=47 | H=51 | N=1 | O=14 | molecular_weight = 853.906 g/mol | bioavailability = 6.5% (oral) | protein_bound = 89 to 98% | metabolism = Hepatic (CYP2C8 and CYP3A4) | elimination_half-life = 5.8 hours | excretion = Fecal and urinary | pregnancy_AU = | pregnancy_US = D | pregnancy_category = | legal_status = Rx-=only | routes_of_administration = iv }} Paclitaxel is a mitotic inhibitor used in cancer chemotherapy. It was discovered in a National Cancer Institute program at the Research Triangle Institute in 1967 when Monroe E. Wall and Mansukh C. Wani isolated it from the bark of the Pacific yew tree, Taxus brevifolia and named it 'taxol'. When it was developed commercially by Bristol-Myers Squibb (BMS) the generic name was changed to 'paclitaxel' and the BMS compound is sold under the trademark 'TAXOL'. In this formulation, paclitaxel is dissolved in Cremophor EL and ethanol, as a delivery agent. A newer formulation, in which paclitaxel is bound to albumin, is sold under the trademark Abraxane.

Welcome to CWAnswers

CWAnswers is your guide to the sprawling world wide web. The directory aims to provide a useful guide made by users. You can share your knowledge as well - simply register and edit your first entry. For questions just contact the team at support - at - cwanswers.com.

Weblinks

Top 10

Things you find nowhere else.

Comments

You must be logged in to post a comment.

No comments yet on this topic. Be the first one!
These recent articles mention Paclitaxel
Medical News Today
... free survival (PFS, the time a patient lives without their cancer progressing), greater objective response rate (ORR, tumour shrinkage), improved tolerability and significant quality of life benefits for IRESSA compared to carboplatin/...
Investors Business Daily
... data-monitoring committee concluded that the study would not meet the primary endpoint of improved overall survival among patients receiving Nexavar, generically sorafenib, combined with the chemotherapeutic agents carboplatin and pacl...
Science Daily
The researchers treated breast cancer cells, in a dish, with one of two standard chemotherapeutic agents, paclitaxel and doxorubicin. They then applied light to the cells at various time intervals and observed the way the light deviated dep...
Genetic Engineering News
Patients in the study received either twice-daily doses of Nexavar or placebo along with carboplatin and paclitaxel over a period of 10 cycles, followed by a maintenance phase of Nexavar or placebo. Nexavar targets cell proliferation and an...
Mass High Tech
He led national oncology medical affairs for paclitaxel, ifosfamide and carboplatin. He also helped launch such cancer therapeutics as dasatinib, cetuximab and ixabepilone. Before he worked at BMS, Smyth served as vice president of medical ...
PharmaceuticalOnline
Bayer HealthCare Pharmaceuticals and Onyx Pharmaceuticals, Inc. recently announced that a Phase 3 trial evaluating Nexavar (sorafenib) tablets in patients with unresectable stage III or stage IV melanoma was stopped early following a planne...
PR Newswire via Yahoo! Finance
Updated Data from Initial Cohort Shows Nine of 14 Evaluable Patients Receiving Bavituximab in Combination with Carboplatin + Paclitaxel Achieved an Objective Tumor Response -